Why choose crescendo biologics? Crescendo Biologics develops potent, multi-functional Humabody ® therapeutics with a focus on novel targeted T-cell engagement. Using our proprietary transgenic mouse platform, we have created a tumour-targeted T-cell engager mechanism capable of activating T-cells only in the tumour microenvironment.What is crescenta biosciences? Crescenta Biosciences Inc. is a small molecule drug discovery company focused on developing novel therapeutic approaches for diseases related to fatty acid metabolism.Where is crescendo located? Crescendo’s premises are located in the Meditrina Building, also known as Building 260. From central Cambridge: Take the A1307 signposted to Haverhill, past Addenbrookes Hospital. Babraham is located a further 3 miles (5km) outside of Cambridge, approximately 6 miles south east of the city centre.
21 October 2021. Crescendo Biologics announces that Zai Lab has achieved proof-of-concept for ZL-1102 (Humabody®, CB001) in a Phase 1b clinical trial in psoriasis patients View PDF.